MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis

Cancer Science

Volumn 105, Issue 2, 2014, Pages 236-243

  Sakamoto, Naoya ^a   Naito, Yutaka ^a   Oue, Naohide ^a   Sentani, Kazuhiro ^a   Uraoka, Naohiro ^a   Zarni Oo, Htoo ^a   Yanagihara, Kazuyoshi ^b   Aoyagi, Kazuhiko ^c   Sasaki, Hiroki ^c   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cancer invasion; Gastric cancer; MicroRNA; MiR 148a; MMP7

Indexed keywords

MATRILYSIN; MICRORNA; MICRORNA 148A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER TISSUE; CELL INVASION; CELL INVASION ASSAY; COMPARATIVE STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE TARGETING; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH MUCOSA; TUMOR INVASION; WESTERN BLOTTING;

CANCER INVASION; GASTRIC CANCER; MICRORNA; MIR-148A; MMP7;

CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 7; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84893782484     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12330     Document Type: Article

References (33)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-62.
2. Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y, Oue N. Molecular pathology of gastric cancer: research and practice. Pathol Res Pract 2011; 207: 608-12.
3. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
5. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-5.
6. Di Leva G, Croce CM. Roles of small RNAs in tumor formation. Trends Mol Med 2010; 16: 257-67.
7. Alexiou P, Maragkakis M, Papadopoulos GL, Reczko M, Hatzigeorgiou AG. Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics 2009; 25: 3049-55.
8. Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res 2011; 39: 6845-53.
9. Zhao X, Dou W, He L et al. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 2013; 32: 1363-72.
10. Tsukamoto Y, Nakada C, Noguchi T et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 2010; 70: 2339-49.
11. Sakamoto N, Oue N, Noguchi T et al. Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma. Cancer Sci 2010; 101: 1038-44.
12. Nagao K, Togawa N, Fujii K et al. Detecting tissue-specific alternative splicing and disease-associated aberrant splicing of the PTCH gene with exon junction microarrays. Hum Mol Genet 2005; 14: 3379-88.
13. Oue N, Sentani K, Sakamoto N et al. Characteristic gene expression in stromal cells of gastric cancers among atomic-bomb survivors. Int J Cancer Suppl 2009; 124: 1112-21.
14. Kondo T, Oue N, Yoshida K et al. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 2004; 64: 523-9.
15. Shinmei S, Sakamoto N, Goto K et al. MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma. Int J Urol 2013; 20: 468-77.
16. Yasui W, Sano T, Nishimura K et al. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression. Int J Cancer Suppl 1993; 54: 49-52.
17. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-6.
18. Hanoun N, Delpu Y, Suriawinata AA et al. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 2010; 56: 1107-18.
19. Matsumura S, Oue N, Mitani Y, Kitadai Y, Yasui W. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer. Int J Cancer Suppl 2007; 120: 1689-95.
20. Sakamoto N, Oue N, Sentani K et al. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer. Cancer Sci 2012; 103: 1744-50.
21. Alley MC, Scudiero DA, Monks A et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601.
22. Zheng B, Liang L, Wang C et al. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 2011; 17: 7574-83.
23. Aprelikova O, Palla J, Hibler B et al. Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility. Oncogene 2013; 32: 3246-53.
24. Cheng P, Chen C, He HB et al. MiR-148a regulates osteoclastogenesis via targeting MAFB. J Bone Miner Res 2013; 28: 1180-90.
25. Song H, Wang Q, Wen J et al. ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a. Int J Mol Sci 2012; 13: 2063-77.
26. Fanelli MF, Chinen LT, Begnami MD et al. The influence of transforming growth factor-alpha, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer. Histopathology 2012; 61: 153-61.
27. Iguchi H, Kosaka N, Ochiya T. Versatile applications of microRNA in anti-cancer drug discovery: from therapeutics to biomarkers. Curr Drug Discov Technol 2010; 7: 95-105.
28. Zhu A, Xia J, Zuo J et al. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. Med Oncol 2012; 29: 2701-9.
29. Ribeiro-dos-Santos A, Khayat AS, Silva A et al. Ultra-deep sequencing reveals the microRNA expression pattern of the human stomach. PLoS One 2010; 5: e13205.
30. Ueda T, Volinia S, Okumura H et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010; 11: 136-46.
31. Chen Y, Song Y, Wang Z et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010; 14: 1170-9.
32. Liffers ST, Munding JB, Vogt M et al. MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest 2011; 91: 1472-9.
33. Bentwich I. Prediction and validation of microRNAs and their targets. FEBS Lett 2005; 579: 5904-10.